Taking people in DenmarkPhase 4
Electrochemotherapy compared with standard radiotherapy for basal cell skin cancer
Compares electrochemotherapy with standard radiotherapy for small basal cell skin cancers in adults.
Key facts
- Who runs it
- Region Hovedstaden
- Where
- Herlev, DenmarkSee the site
- Registry title
- Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 52 people, planned
- Started
- 16 Nov 2020
- Expected to end
- 15 Dec 2028
- Type of study
- Interventional
- Record updated
- 16 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with biopsy-confirmed basal cell carcinoma, a type of skin cancer, smaller than 3 cm (1.2 in). It compares electrochemotherapy with standard radiotherapy.
- Age
- Above 18 years
- Sex
- All sexes
- Disease stage
- Basal cell carcinoma confirmed by biopsy, under 3 cm (1.2 in), that can be treated with both radiotherapy and electrochemotherapy
- Earlier treatment
- Previous bleomycin above 200.000 Units/m2 is not allowed
Main reasons for not taking part
- Basal cell carcinoma that has spread (metastatic)
- Previous bleomycin above 200.000 Units/m2
- Previous severe allergic reaction to bleomycin
- Pregnancy or breast feeding
- Taking part in other trials with trial medication
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age above 18 years
- Biopsy verified basal cell carcinoma under 3 cm accessible for both radiotherapy and elechtrochemoterapy
- Subject must understand patient information
- Signed informed consent
Who cannot take part
- Previous treatment with bleomycin above 200.000 Units/m2
- Previous severe allergic reactions to bleomycin
- Participation in other trials with trial medication
- Metastatic basal cell carcinoma
- Pregnancy or breast feeding
Where in Denmark
- Region HovedstadenHerlev, DenmarkTaking people
About the trial
What the trial wants to find out
To compare effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma
- Plain-language title
- Electrochemotherapy compared with standard radiotherapy for basal cell skin cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 16 December 2024